Q3 2017 EPS Estimates for Sabra Healthcare REIT, Inc. Raised by SunTrust Banks (SBRA)
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) – Equities research analysts at SunTrust Banks lifted their Q3 2017 earnings per share estimates for Sabra Healthcare REIT in a research note issued on Thursday. SunTrust Banks analyst E. Fleming now forecasts that the real estate investment trust will post earnings of $0.59 per share for the quarter, up from their prior forecast of $0.56. SunTrust Banks also issued estimates for Sabra Healthcare REIT’s Q4 2017 earnings at $0.60 EPS, Q2 2018 earnings at $0.64 EPS, Q3 2018 earnings at $0.60 EPS, Q4 2018 earnings at $0.62 EPS, FY2018 earnings at $2.46 EPS and FY2019 earnings at $2.69 EPS.
Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, May 8th. The real estate investment trust reported $0.25 earnings per share for the quarter, missing the consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a return on equity of 8.72% and a net margin of 34.99%. The business had revenue of $62.65 million for the quarter, compared to the consensus estimate of $63.47 million. During the same quarter last year, the business posted $0.54 earnings per share. The firm’s revenue for the quarter was up .1% compared to the same quarter last year.
COPYRIGHT VIOLATION NOTICE: This report was first posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The legal version of this report can be read at https://www.americanbankingnews.com/2017/08/07/q3-2017-eps-estimates-for-sabra-healthcare-reit-inc-raised-by-suntrust-banks-sbra.html.
Several other equities analysts have also commented on SBRA. Stifel Nicolaus reaffirmed a “hold” rating and issued a $26.00 price target on shares of Sabra Healthcare REIT in a research note on Friday, July 28th. Zacks Investment Research raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. BidaskClub raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $25.00 price target (down previously from $28.00) on shares of Sabra Healthcare REIT in a research note on Sunday, July 9th. Finally, Mizuho lowered Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $25.00 to $23.00 in a research note on Monday, July 10th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $26.57.
Shares of Sabra Healthcare REIT (NASDAQ:SBRA) opened at 23.09 on Monday. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 19.44 and a beta of 0.89. Sabra Healthcare REIT has a 52-week low of $19.30 and a 52-week high of $29.10.
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 17th. Investors of record on Wednesday, August 16th will be paid a dividend of $0.3599 per share. This represents a $1.44 annualized dividend and a yield of 6.23%. The ex-dividend date is Monday, August 14th. Sabra Healthcare REIT’s payout ratio is 145.76%.
A number of institutional investors have recently bought and sold shares of SBRA. Russell Investments Group Ltd. purchased a new position in Sabra Healthcare REIT during the fourth quarter valued at about $120,000. AQR Capital Management LLC raised its position in Sabra Healthcare REIT by 0.4% in the fourth quarter. AQR Capital Management LLC now owns 42,382 shares of the real estate investment trust’s stock valued at $1,035,000 after buying an additional 171 shares during the last quarter. Norges Bank purchased a new position in Sabra Healthcare REIT during the fourth quarter valued at about $18,208,000. Teachers Advisors LLC raised its position in Sabra Healthcare REIT by 5.3% in the fourth quarter. Teachers Advisors LLC now owns 738,716 shares of the real estate investment trust’s stock valued at $18,039,000 after buying an additional 37,156 shares during the last quarter. Finally, Creative Planning raised its position in Sabra Healthcare REIT by 6.3% in the first quarter. Creative Planning now owns 14,248 shares of the real estate investment trust’s stock valued at $398,000 after buying an additional 848 shares during the last quarter. 99.26% of the stock is currently owned by hedge funds and other institutional investors.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.